With the aim of protecting the swiss market and patients from counterfeit or substandard medicines, the regulating authority, the Swiss Agency for therapeutic products or Swissmedic, limits personal imports to a maximum quantity equivalent to one month of therapy at a standard dosage as indicated, for example, in the patient information leaflet.